From Stigma to Street Cred: Tech Transfer Is Gaining Ground | GenomeWeb

David Ward remembers the days before technology transfer offices. Ward, deputy director of the Nevada Cancer Institute and a scientist with some 40 patents to his name, says that in the early days getting a patent meant having to hunt down an external licensee yourself to convince your university that the technology would be worthwhile before it would assign someone to handle the paperwork and prosecution of the patent. “You had to lobby to get it done,” he recalls.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.